Submissions & Templates

  • ONLINE Documents
  • Confidential Disclosure
  • Material Transfer
  • Sponsored Research
  • Service
  • Invention Disclosure

UNDER CONSTRUCTION.

ONLINE SUBMISSIONS ARE AVAILABLE FOR:

  1. Intellectual Property Disclosure (IPO)
  2. Agreement: Material Transfers into UHN (MTA in)
  3. Agreement: Material Transfers from UHN (MTA out)

 

Note:

  1. For MTAs: Please ensure that you have either the completed UHN template (MTA out) or the providing party's template (MTA in) prior to submission of an MTA request to the Technology Development and Commercialization (TDC) Office.  You will also need to provide Research Ethics Board (REB) approval for any MTA where REB approval is required.  To select the appropriate MTA template for materials sent out from UHN, please go HERE.
  2. For IPDs: all information is submitted online and a document, to be signed by all listed UHN inventors, is provided by the TDC Office shortly after the online submission.

 

To make a submission, please login HERE.

General instructions on how to submit online can be found HERE.

If you have any queries regarding Intellectual Property Disclosures (IPDs), or would like to provide comments or feedback regarding the online access, please call: 18-7832 or email martin.haardt@uhnresearhc.ca at the TDC Office.

If you have any queries regarding MTAs, please call: 18-8813 or email: MTAs@uhnresearch.ca at the TDC Office.

 

COMING SOON - ONLINE SUBMISSIONS FOR THE UHN COMMUNITY FOR:

- Confidential Disclosure Agreement (CDA)

- Sponsored Research Agreement (SRA)

- Service Agreement (SA)

 

To obtain the above agreement and document templates please refer to the respective tab in the Submissions and Templates menu (for the UHN Community) or the Documents & Templates menu (for the Industry): click here.

For ALL COMMERCIAL requests please contact: MTAs@uhnresearch.ca.

COMING SOON! ONLINE SUBMISSION FOR CDAs - STAY TUNED FOR FUTURE ANNOUNCEMENTS

 

Confidential Disclosure Agreement (CDA) Template

A CDA is a legal contract that governs the sharing of confidential information. UHN's template CDAs ensure that disclosures in either direction, intended or otherwise, are covered by confidentiality.  A CDA needs to be in place before disclosing or receiving confidential information.

 

   CDAs are important because they:

  • Protect confidential information being shared. 
  • Outline and limit the purpose for which the information is being shared.
  • Preserve the ability to patent the invention(s) being disclosed.

 

To transfer and protect confidential information shared between two parties, please use UHN's  Confidential Disclosure Agreement template.  Once reviewed and signed, please email the partially signed CDA to the attention of TDC at tdc@uhnresearch.ca(link sends e-mail).

All CDAs involving UHN researchers must be reviewed by TDC.  Use of the UHN template will avoid delays in processing. Please contact TDC with any questions. ​

 

 

COMING SOON! ONLINE SUBMISSION FOR MTAs - STAY TUNED FOR FUTURE ANNOUNCEMENTS

 

Material Transfer Agreement (MTA) Templates

The Technology Development and Commercialization (TDC) office at the University Health Network (UHN) must review and approve all MTAs prior to the transfer of any such materials.  

The following templates are intended for use by UNIVERSITIES and NOT-FOR-PROFIT organizations.  For ALL COMMERCIAL requests please contact: MTAs@uhnresearch.ca.

 

doc: doc1.docx

 

Agreement Type

Material to be Transferred

REB Requirements

Download the below template

1)​ Human Tissue related to Clinical Trial

  1. These transfers need to be co-ordinated with the Clinical Trial Group. Please contact them @ clinicaltrials@uhnresearch.ca  with your CAPCR/REB# to begin the process.
  • Required

N/A

2) Human Tissue NOT related to Clinical Trial

  1. Human bodily fluids (i.e., blood, saliva, urine, etc.).
  2. Human biopsy samples (i.e., tumour samples).
  3. Human isolated DNA, RNA, proteins etc. or fragments thereof.

 

  • Mice or other animals carrying human tumour transplants or other human material contact UHN MTAs @ MTAs@uhnresearch.ca
  • Required
  • The REB has approved the proposed transfer and use of the materials to non-UHN parties.

UHN MTA Human-Derived Sep2518.docx

3) Mice Transfer

 

  1. Transgenic mice.
  2. Knock-out mice.
  3. Any otherwise altered mice.

 

EXCEPTION:

Does not include mice carrying human-derived material, e.g., tumour transplants (PDX, xenograft, derived from xenograft, etc.). Transgenic mice carrying human-derived material require either Human Tissue related to Clinical Trial or Human Tissue NOT related to Clinical Trial MTA.

  • Not required

UHN MTA Mouse Transfer Sep2518.docx

4) Biological Material

Research reagents such as:

  1. Non-human biological materials, e.g., DNA, RNA, plasmids, antibodies, proteins, viruses, bacteria, etc.
  2. Modified human cell lines and non-human cell lines.
  3. Buffers and solutions.
  • Not required

UHN Biological Material MTA Sep2518.docx

5) H6c7 pancreatic cell line

  1. H6c7 pancreatic cell line from Dr. Tsao.
  • Not required

UHN-MTA-H6c7.docx

 

 

COMING SOON! ONLINE SUBMISSION FOR SRAs - STAY TUNED FOR FUTURE ANNOUNCEMENTS.

 

Sponsored Research Agreements (SRA)

Sponsored Research Agreements (SRAs) are used when industry, government or another non-academic third party (ie, the sponsor) wishes to work collaboratively with a UHN investigator, or team, to pursue a project of mutual interest, and is willing to provide financial support in pursuit of the project.        

Both Service Agreements and Sponsored Research Agreements are subject to institutional overhead, at a rate of 40%.

Please contact TDC to discuss the details of your situation or interest in collaborative research at UHN.

COMING SOON! ONLINE SUBMISSION FOR SAs - STAY TUNED FOR FUTURE ANNOUNCEMENTS.

 

Service Agreements (SAs)

 Service Agreements (SAs)are used when industry, government or another non-academic third party (ie, the requestor) is looking to engage a UHN investigator, or team, to perform research tasks on behalf of the requestor. UHN investigators tend to prefer more collaborative arrangements, such as Sponsored Research Agreements.

The Service Agreement template can be found here: Service Agreements.

Please contact TDC(link is external) to discuss the details of your situation or interest in collaborative research at UHN.

 

Intellectual Property (Invention) Disclosure (IPD)

UHN’s Intellectual Property Policy (link available on the UHN research network) requires UHN employees to submit an Intellectual Property Disclosure (also known as an Invention Disclosure) to the TDC Office upon making a discovery or creating something with commercial potential.

Examples include new therapeutics entities such as small-molecules, NCEs or biologics, diagnostic methods, medical devices, software, clinical tools or questionnaires.

By submitting an Invention Disclosure, you will enable the exploration of commercialization opportunities for your invention, while legally protecting its future marketability.

 
When should I file an Invention Disclosure?
 As soon as your invention or work can be clearly described.

 Prior to making any public disclosure of your work (i.e., abstract submission, poster presentation, or journal publication).

To submit an Intellectual Property Disclosure, please login HERE.

Please contact the TDC Office at tdc@uhnresearch.ca to discuss the details of your situation and to answer any questions you may have.